On Oct. 22, 2024, the Securities and Exchange Commission (SEC) announced settled charges against four current and former public companies, Unisys, Avaya Holdings, Check Point Software Technologies and Mimecast, for allegedly making materially misleading statements in their public disclosures regarding cybersecurity intrusions and risks following the SolarWinds Corporation software hack. This wave of enforcement actions
Enforcement Risks for Private Equity Investors in Healthcare, With Michael J. Podberesky, Former DOJ Prosecutor
The U.S. Department of Justice has annunciated several enforcement priorities relevant to the healthcare sector: senior care, opioids, cybersecurity and privacy, and – of particular interest to listeners of “The Corner Series” – private equity investors in the healthcare space.
Michael Podberesky, a former DOJ prosecutor who is now co-chair of McGuireWoods’ False…
Notable Litigation – September 2024
Notable litigation filed during September 2024 includes: (1) Williamson, et al. v. Linarducci, et al., No. 24-cv-01526 (S.D. Ind.); (2) Perrotta v. First Edge, LLC, et al., No. 24-cv-01638 (M.D. Fla.); (3) Next Gen. Inv. Grp., LLC, et al. v. Pure Health Enters., Inc., et al., No. 24-cv-06764 (N.D. Cal.); (4) Commodity…
Healthcare & Life Sciences Private Equity Deal Tracker: THL Acquires Red Nucleus
By Kevin Madagan
Thomas H. Lee Partners (THL) has acquired Red Nucleus, according to a news release.
Red Nucleus, founded in 1991 and based in Yardley, Pennsylvania, is a life sciences communication firm.
THL, based in Boston, is a private equity firm investing in middle market growth companies in three sectors, including…
DoD Issues Final CMMC Framework for Defense Contractors
After a nearly five-year rulemaking process, the U.S. Department of Defense (DoD) published the Final Cybersecurity Maturity Model Certification 2.0 (CMMC) program rule in the Federal Register on Oct. 15, 2024, codified at 32 CFR Part 170. Contract clauses implementing the CMMC program rule will be issued as part of the Defense Federal Acquisition Supplement,…
Improving Oral and Maxillofacial Surgery Practice through Private Equity, With Daniel Hosler and Dr. David Kostohryz
The business side of operating an oral and maxillofacial surgery practice can present challenges, such as purchasing the latest equipment, staffing offices and dealing with technology and cybersecurity. That’s where private equity and a group run by doctors can help.
With host Geoff Cockrell, Daniel Hosler, who brings experience in equity, and …
Healthcare & Life Sciences Private Equity Deal Tracker: Frazier Acquires DirectMed Imaging From NMS
Frazier Healthcare Partners has announced it has completed the acquisition of DirectMed Imaging from NMS Capital.
DirectMed, founded in 2012 and based in Poway, California, is a provider of aftermarket parts and component repairs for diagnostic imaging equipment
Frazier, based in Seattle, is a provider of private equity capital to healthcare companies. The…
Healthcare & Life Sciences Private Equity Deal Tracker: GTCR to Acquire TRANZACT
GTCR has announced it will acquire TRANZACT.
TRANZACT, founded in 1997 and based in Fort Lee, New Jersey, is a direct-to-consumer insurance services company. The company states it is the agent of record for more than 1 million active insurance policies across the Medicare Advantage, Medicare supplement, and life and supplemental insurance markets.
GTCR…
Crypto.com Sues the SEC in Texas – Arguments and Implications for the Cryptocurrency Industry
On October 8, 2024, Crypto.com filed a civil complaint against the Securities and Exchange Commission (“SEC”) and each of its Commissioners in the Eastern District of Texas seeking declaratory and injunctive relief. Crypto.com sued the SEC after the regulator sent it a Wells notice, indicating the Division of Enforcement intended to recommend an enforcement action against the Company for operating as an unregistered securities broker-dealer and an unregistered clearing agency in connection with secondary-market sales of certain Targeted Network Tokens.[1]
Renovus Closed New Fund at $875 Million
Renovus Capital Partners has announced it has closed its fourth private equity fund.
The fund, Renovus Capital Partners IV Core Buyout, was oversubscribed and had total capital commitments of $875 million. It will focus on control investments in founder-owned small and mid-sized businesses in the lower middle market.
Renovus, based in Philadelphia, is a…